Viral Decay Dynamics in HIV-Infected Patients Receiving Ritonavir-Boosted Saquinavir and Efavirenz With or Without Enfuvirtide: A Randomized, Controlled Trial (HIV-NAT 012).

MLA

Boyd, Mark A., et al. “Viral Decay Dynamics in HIV-Infected Patients Receiving Ritonavir-Boosted Saquinavir and Efavirenz With or Without Enfuvirtide: A Randomized, Controlled Trial (HIV-NAT 012).” Journal of Infectious Diseases, vol. 194, no. 9, Nov. 2006, pp. 1319–22. EBSCOhost, https://doi.org/10.1086/508291.

APA

Boyd, M. A., Dixit, N. M., Siangphoe, U., Buss, N. E., Salgo, M. P., Lange, J. M. A., Phanuphak, P., Cooper, D. A., Perelson, A. S., & Ruxrungtham, K. (2006). Viral Decay Dynamics in HIV-Infected Patients Receiving Ritonavir-Boosted Saquinavir and Efavirenz With or Without Enfuvirtide: A Randomized, Controlled Trial (HIV-NAT 012). Journal of Infectious Diseases, 194(9), 1319–1322. https://doi.org/10.1086/508291

Chicago

Boyd, Mark A., Narendra M. Dixit, Umaporn Siangphoe, Neil E. Buss, Miklos P. Salgo, Joep M. A. Lange, Praphan Phanuphak, David A. Cooper, Alan S. Perelson, and Kiat Ruxrungtham. 2006. “Viral Decay Dynamics in HIV-Infected Patients Receiving Ritonavir-Boosted Saquinavir and Efavirenz With or Without Enfuvirtide: A Randomized, Controlled Trial (HIV-NAT 012).” Journal of Infectious Diseases 194 (9): 1319–22. doi:10.1086/508291.